Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


We need to find safer drugs for patients

Seeing the headline ‘Everyday drugs raise the risk of dementia’ in The Times made me realise that we, as pharmacists, must look more into this subject.

I’m sure most pharmacists would agree that we chose our profession to help people, not to make them worse.

In the past year, there were 66,000 drugs overdose-related deaths in the United States. The persistent rise in overdose deaths over the past few years has largely been attributed to opioid addiction and the growing prevalence of fentanyl in the illegal drug market.

However, The Times wasn’t talking about opioid addiction, but the hundreds of thousands of people in the UK who are routinely taking medicines that increase their risk of dementia by up to a third.

And a BBC Radio 4 programme, ‘A Deadly Prescription’, broadcast in February 2018, reported that a 21-year-old died from taking her prescription drugs.

We know that virtually all drugs available on prescription have side effects, and we let our customers know these. But wouldn’t it be better if we could utilise drugs that didn’t have these side effects or sometimes cause death?

There is no point in giving people medicines if there is some chance that the patient will get worse. We have to get very clever and find healthy medicines of which we, as pharmacists, can be proud.

Sheila Gaiman

Member of the Royal Pharmaceutical Society

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204882

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.